Skip to content


News: General News

It took nearly two decades, but a little known research project at Massachusetts General Hospital is shaping up as a potentially powerful weapon in the fight against ovarian cancer.
The results from a 15-year study conducted by the University College London appear to be the most-promising signs yet that a locally developed technology can catch the disease at its earliest stages using a blood test. In the study, 20 percent fewer women who were screened using the test died from ovarian cancer compared to women who weren’t screened at all.

Get the full story here